Novavax, Inc. (NVAX)
8.855
-0.08
(-0.95%)
USD |
NASDAQ |
Aug 24, 16:00
8.86
0.00 (0.00%)
After-Hours: 20:00
Novavax Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2025 | 36.93 |
| September 26, 2025 | 36.85 |
| September 25, 2025 | 35.94 |
| September 24, 2025 | 37.24 |
| September 23, 2025 | 37.37 |
| September 22, 2025 | 38.23 |
| September 19, 2025 | 37.54 |
| September 18, 2025 | 36.76 |
| September 17, 2025 | 36.16 |
| September 16, 2025 | 36.89 |
| September 15, 2025 | 34.82 |
| September 12, 2025 | 34.39 |
| September 11, 2025 | 35.69 |
| September 10, 2025 | 34.31 |
| September 09, 2025 | 34.31 |
| September 08, 2025 | 33.31 |
| September 05, 2025 | 34.05 |
| September 04, 2025 | 33.57 |
| September 03, 2025 | 31.89 |
| September 02, 2025 | 32.54 |
| August 29, 2025 | 32.19 |
| August 28, 2025 | 32.67 |
| August 27, 2025 | 32.67 |
| August 26, 2025 | 32.32 |
| August 25, 2025 | 32.41 |
| Date | Value |
|---|---|
| August 22, 2025 | 33.79 |
| August 21, 2025 | 32.88 |
| August 20, 2025 | 37.67 |
| August 19, 2025 | 41.03 |
| August 18, 2025 | 41.85 |
| August 15, 2025 | 41.29 |
| August 14, 2025 | 40.64 |
| August 13, 2025 | 38.14 |
| August 12, 2025 | 36.55 |
| August 11, 2025 | 34.61 |
| August 08, 2025 | 36.07 |
| August 07, 2025 | 37.84 |
| August 06, 2025 | 32.67 |
| August 05, 2025 | 29.00 |
| August 04, 2025 | 29.09 |
| August 01, 2025 | 28.27 |
| July 31, 2025 | 28.66 |
| July 30, 2025 | 29.52 |
| July 29, 2025 | 30.21 |
| July 28, 2025 | 31.38 |
| July 25, 2025 | 32.19 |
| July 24, 2025 | 32.93 |
| July 23, 2025 | 33.79 |
| July 22, 2025 | 31.12 |
| July 21, 2025 | 30.90 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Moderna, Inc. | 8.192 |
| Merck & Co., Inc. | 8.873 |
| Pfizer Inc. | 1.872 |
| Recursion Pharmaceuticals, Inc. | 1.894 |
| Agenus, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 3.506 |
| Price | 8.855 |
| Earnings Yield | -17.20% |
| Market Cap | 1.459B |